CellCarta Joins Olink™ Certified Service Provider Network in China

CellCarta has become a Certified Service Provider (CSP) of Olink in China, demonstrating its commitment to delivering Olink workflows with the highest standards of quality and consistency.

This certification provides biopharma companies operating in China with added confidence in CellCarta’s ability to generate reliable, high-quality Olink data, empowering biomarker discovery and advancing clinical research.

As one of only four Olink CSPs in China, CellCarta brings a new level of assurance to biopharma sponsors in the region. The certification ensures that Olink workflows are performed with the same rigor and excellence found in Olink’s own facilities. To maintain this elite status, CellCarta’s lab will undergo annual concordance testing and re-certification, guaranteeing continued excellence in Olink assay performance.

“Becoming an Olink CSP in China is the latest step in our journey to help advance and optimize our customers’ studies in the region,” said Todd Chermack, Senior Vice President and Global Business Head Immunology and Proteomics at CellCarta. “Alongside our existing proteomics capabilities, Olink technologies can help our sponsors get the deep and reliable proteomic insights they need to advance their science – now with an added level of confidence in our extensive expertise with Olink assays.”

Using Olink’s Signature Q100 instruments with Target 96 and 48 panels, Flex panels and Focus assays, CellCarta can deliver high-throughput, accurate protein analysis covering Phase 1 to 3 clinical trial programs. The Olink Target 96 and 48 panels focus on specific disease areas or biological processes and enable quantification of up to 92 proteins across 88 samples simultaneously, using as little as 1 µL of almost any biological sample. This unique approach ensures robust, high-quality data, even from minimal sample volumes, making Olink’s PEA™ technology ideal for studies involving low-abundance biomarkers, such as those in immuno-oncology.

For more information about how CellCarta can support your clinical research with Olink, visit: Olink PEA Technology | CellCarta